Skip to main content
Log in

Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: Correlation with stage and rate of progression

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Plasma levels of platelet-derived growth factor (PDGF) were measured in 58 female patients with breast cancer and in 9 normal female control subjects by means of a specific radioimmunoassay. Levels in normal control subjects were all below the lower limits of detection by the assay (1.56 fmol/100 µl plasma). Two of 17 (12%) patients with stage 2 breast cancer had detectable plasma levels. Among patients with Stage 4 breast cancer 13/41 (32%) had significantly elevated levels (> 2 times the lower limit of sensitivity of the assay). Patients with elevated PDGF levels had a significantly greater degree of metastatic involvement and significantly shorter survival. Apart from being a marker of aggressive high bulk breast cancer, PDGF may be involved in the acceleration of growth of some metastatic breast tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Heldin C-H, Westermark B: Growth factors: mechanism of action and relation to oncogenes. Cell 37: 9–20, 1984

    PubMed  Google Scholar 

  2. Antoniades HN, Owen AJ: Growth factors and regulation of cell growth. Ann Rev Med 33: 445–463, 1988

    Google Scholar 

  3. Ogaswara M, Subuska DA: A new serum-free method of measuring growth factor activities for human breast cancer cells in culture.In Vitro Cell Devel Biol 24: 911–920, 1988

    Google Scholar 

  4. Doolittle RF, Hunkapiller M, Hood L, Devare S, Robbins K, Aaronson SA, Antoniades HN: Simian sarcoma virus oncogene, V-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221: 275–276, 1983

    PubMed  Google Scholar 

  5. Waterfield M, Scrace G, Whittle H, Stroobant P, Johnsson A, Wasteson A, Westermark B, Heldin C-H, Huang J, Deuel T: Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 304: 35–39, 1983

    PubMed  Google Scholar 

  6. Delarco J, Todaro GJ: Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 75: 4001–4005, 1978

    PubMed  Google Scholar 

  7. Downward J, Yarden Y, Mayes E, Scrace G, Totty M, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD: Close similarity of epidermal growth factor receptor and V-erb-B oncogene protein sequences. Nature 307: 521–527, 1984

    PubMed  Google Scholar 

  8. Hasselbacker GK, Irminger JC, Zapf J, Ziegler WH, Humbel RE: Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein levels. Proc Natl Acad Sci USA 84: 1104–1106, 1987

    PubMed  Google Scholar 

  9. Peres R, Betscholtz C, Westermark B, Heldin CH: Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res 47: 3421–3429, 1987

    PubMed  Google Scholar 

  10. Ohmura E, Okuda M, Onoda N, Kamiya Y, Murakani H, Tsushima T, Shizume K: Insulin-like growth factors and transforming growth factor α as autocrine growth factors in pancreatic cancer cell growth. Cancer Res 50: 103–107, 1990

    PubMed  Google Scholar 

  11. Solomon DS, Zwiebel JA, Bano D, Losonczy I, Fehnel P, Kidwell WR: Presence of transforming growth factor in human breast cancer cells. Cancer Res 44: 4069–4077, 1984

    PubMed  Google Scholar 

  12. Sporn MB, Roberts AB, Wakerfield LM, Assosia RK: Transforming growth factor β: biological function and chemical structure. Science 233: 532–534, 1986

    PubMed  Google Scholar 

  13. Knabbe C, Lippman ME, Wakerfield LM, Flanders KV, Kasid A, Derynck R, Dickson RB: Evidence that transforming growth factor β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417–418, 1987

    PubMed  Google Scholar 

  14. Bronzert DA, Pantazis P, Antoniades HN, Kasid A, Davidson N, Dickson RB, Lippman ME: Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci USA 84: 5763–5767, 1987

    PubMed  Google Scholar 

  15. Kasid A, Lippman ME: Estrogen and oncogene mediated growth regulation of human breast cancer cells. J Steroid Biochem 27: 465–470, 1987

    PubMed  Google Scholar 

  16. Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL: Epidermal growth factor receptor as a predictor of early recurrence and death from breast cancer. Lancet i: 1398–1402, 1987

    Google Scholar 

  17. Spitzer E, Grosse R, Kunde D, Schmidt HE: Growth of mammary epithelial cells in breast cancer biopsies correlates with EGF binding. Int J Cancer 39: 279–282, 1987

    PubMed  Google Scholar 

  18. Patterson AH, Lees AW, Jamil N, Dietrich KD, Huson J, Fourney RM, Salmon DJ, Patterson MC, Danyluk J: Comparison of Her-2/neu oncogene amplification with other prognostic factors in node negative patients with breast cancer. Proc ASCO 8: 99, 1989

    Google Scholar 

  19. Lupu R, Colomer R, Zugmaier G, Sarup J, Shepard M, Slamon D, Lippman ME: Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2. Science 249: 1552–1555, 1990

    PubMed  Google Scholar 

  20. Westphal M, Branchen M, Rhode E, Herrman HD: Growth factors in cultured human glioma cells: differential effects of FGF, EFG, and PDGF. Cancer Lett 38: 283–296, 1988

    PubMed  Google Scholar 

  21. Bates SE, McManaway M, Lippman ME, Dickson RB: Characterisation of estrogen responsive transforming activity. Cancer Res 46: 1707–1713, 1986

    PubMed  Google Scholar 

  22. Pantazis P, Goustin AS, Nixon J: Platelet-derived growth factor and its receptor in blood cell differentiation and neoplasia. Eur J Haematol 45: 127–138, 1990

    PubMed  Google Scholar 

  23. Ross R, Raines EW, Bowen-Pope DF: The biology of platelet-derived growth factor. Cell 46: 155–169, 1986

    PubMed  Google Scholar 

  24. Nister M, Hammacher A, Mellstrom K: A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF heterodimer purified from human platelets. Cell 52: 791–799, 1988

    PubMed  Google Scholar 

  25. Yarden Y, Escobedo JA, Kuang W-J, Yang-Feng TL, Daniel TO, Tremble PM, Chen EY, Ando ME, Harkins RN, Francke U, Freed VA, Ullrich A, Williams L: Structure of the receptor for platelet-derived growth factor helps to define a family of closely related receptors. Nature 323: 226–232, 1986

    PubMed  Google Scholar 

  26. Bowen-Pope DF, Malpass TW, Foster DM, Ross R: Platelet-derived growth factorin vivo: levels, activity, and rate of clearance. Blood 64: 458–469, 1984

    PubMed  Google Scholar 

  27. Raines EW, Bowen-Pope EF, Ross R: Plasma binding protein for platelet-derived growth factor that inhibit its binding to cell-surface receptors. Proc Natl Acad Sci USA 81: 3424–2438, 1984

    PubMed  Google Scholar 

  28. Bernabei PA, Arcangeli A, Casini M, Grossi A, Padovani R, Rossi Ferrini P: Platelet-derived growth factor(s) mitogenic activity in patients with myeloproliferative disease. Brit J Haematol 63: 353–357, 1986

    Google Scholar 

  29. Mannucci PM, Cattaneo M, Canciani MT, Manniezzo M, Vaglini M, Cascinelli N: Early presence of activated (exhausted) platelets in malignant tumors (breast adenocarcinoma and malignant melanoma). Eur J Cancer Clin Oncol 25: 1413–1417, 1989

    PubMed  Google Scholar 

  30. Panatzis P, Sariban E, Kufe D, Antoniades HN: Induction of C-sis gene expression and synthesis of platelet-derived growth factor in human myeloid leukemia cells during monocytic differentiation. Proc Natl Acad Sci USA 83: 6455–6459, 1986

    PubMed  Google Scholar 

  31. Papayannopoulou T, Raines E, Collins S, Nakamoto B, Tweedale M, Ross R: Constitutive and inducible secretion of platelet-derived growth factor analogs by human leukemic cell lines co-expressing erythroid and megakaryocytic markers. J Clin Invest 79: 859–866, 1987

    PubMed  Google Scholar 

  32. Eva A, Robbins KS, Anderson PR: Cellular genes analogous to retroviral oncogenes are transcribed in human tumor cells. Nature 295: 116–119, 1982

    PubMed  Google Scholar 

  33. Gerwin BI, Lechner JF, Reddel RR, Roberts AB, Robbins KC, Gabrielson FW, Harris CC: Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res 47: 6180–6184, 1987

    PubMed  Google Scholar 

  34. Fraizer GE, Bowen-Pope DF, Vogel AM: Production of platelet derived growth factor by cultured Wilms tumor cells. J Cell Physiol 133: 169–174, 1987

    PubMed  Google Scholar 

  35. Rodeck U, Koprowski H: Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor. Proc Natl Acad Sci USA 83: 7197–7200, 1986

    PubMed  Google Scholar 

  36. Sitaras NM, Saiban E, Bravo M, Pantazis P, Antoniades HM: Constitutive production of platelet-derived growth factor like proteins by human prostate-carcinoma cell lines. Cancer Res 48: 1930–1935, 1988

    PubMed  Google Scholar 

  37. Golombick T, Bezwoda WR: Long term growth of a new ovarian cancer cell line UWOV2 (pf) in tissue culture in the absence of exogenous serum factors, proteins transferrin and insulin: a potential model for autonomous growth and tumor progression. Eur J Cell Biol (in press)

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ariad, S., Seymour, L. & Bezwoda, W.R. Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: Correlation with stage and rate of progression. Breast Cancer Res Tr 20, 11–17 (1991). https://doi.org/10.1007/BF01833352

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01833352

Key words

Navigation